Harrow Inc (NAS:HROW)
$ 11.6 1.31 (12.73%) Market Cap: 410.43 Mil Enterprise Value: 518.16 Mil PE Ratio: 0 PB Ratio: 5.77 GF Score: 80/100

Q4 2020 Harrow Health Inc Earnings Call Transcript

Mar 08, 2021 / 09:45PM GMT
Release Date Price: $8.03 (+1.01%)
Operator

Good afternoon, and welcome to the Harrow Health's Q4 2020 Earnings Conference Call. My name is John, and I will be your operator for today's call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the call over to Jamie Webb, Director of Communications and Investor Relations for Harrow Health. Jamie, please go ahead.

Jamie Webb

Thank you, John. Good afternoon, and welcome to Harrow Health's fourth quarter 2020 earnings conference call. Before we begin today, let me remind you that the company's remarks may include forward-looking statements within the meaning of federal securities laws. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond Harrow Health's control, including risks and uncertainties described from time to time in its SEC filings, such as the risks and uncertainties related to the company's ability to make commercially available its compounded formulations and technologies, and FDA approval of certain drug candidates in a timely manner or at all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot